GSK Offers Concessions on Pfizer JV to Quell EU Antitrust Fears

Date : 06/20/2019 @ 11:53AM
Source : Dow Jones News
Stock : GlaxoSmithKline PLC (GSK)
Quote : 41.32  0.19 (0.46%) @ 9:35PM

GSK Offers Concessions on Pfizer JV to Quell EU Antitrust Fears

Glaxosmithkline (LSE:GSK)
Historical Stock Chart

2 Months : From May 2019 to Jul 2019

Click Here for more Glaxosmithkline Charts.

By Carlo Martuscelli


GlaxoSmithKline PLC (GSK.LN) has offered unspecified concessions to address competition concerns over its proposed healthcare joint venture with Pfizer Inc. (PFE), the European Commission said Thursday.

The EU authority said it will come to a decision on the proposed combination by July 10.

The U.K. pharmaceutical company in December said it planned to create a consumer health-focused joint venture with U.S. drugmaker Pfizer, with the aim of eventually spinning it off.

The plans are being investigated by the EU's competition body to make sure that they don't breach market rules.


Write to Carlo Martuscelli at


(END) Dow Jones Newswires

June 20, 2019 06:38 ET (10:38 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest GSK Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.